2-(bromomethyl)-9H-xanthen-9-one | 54160-09-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 2-(bromomethyl)-9H-xanthen-9-one
• 英文别名: 2-bromomethylxanthone；2-Bromomethyl-9H-xanthen-9-one；2-(bromomethyl)xanthen-9-one
• CAS: 54160-09-7
• 化学式: C₁₄H₉BrO₂
• 分子量: 289.128
• InChiKey: QUNBOLUFOMCEDB-UHFFFAOYSA-N

物化性质

• 熔点：
  180-182 °C(Solv: ethanol (64-17-5))
• 沸点：
  433.1±34.0 °C(Predicted)
• 密度：
  1.578±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(bromomethyl)-9H-xanthen-9-one 在 硫酸 、 水 、 溶剂黄146 作用下， 以 乙醇 、 水 为溶剂， 生成 xanthone-2-acetic acid
  参考文献：
  名称：

  Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo

  摘要：

  In a search for compounds related to flavoneacetic acid with activity against solid tumors, a series of methyl-, methoxy-, chloro-, nitro-, and hydroxy-substituted xanthenone-4-acetic acids have been synthesized and evaluated against subcutaneously implanted colon adenocarcinoma 38 in vivo, using a short-term histology assay as a primary screening system. A major goal of this work was to identify compounds with similar profiles of activity to that of flavoneacetic acid but of higher potency. The level of activity of the compounds appeared to depend more on the nature of the substituent than its positioning, in the order Cl greater than Me, OMe greater than NO2, OH. However, the potency of the compounds was related much more to the position rather than the nature of the substitution, with 5-substituted compounds being clearly the most dose potent. 5-Methylxanthenone-4-acetic acid has a similar level of activity to that of flavoneacetic acid in the test systems employed but is more than 7-fold as dose potent.

  DOI：

  10.1021/jm00124a012
• 作为产物：
  描述：

  2-methyl-9H-xanthen-9-one 在 N-溴代丁二酰亚胺(NBS) 、 过氧化苯甲酰 作用下， 以 四氯化碳 为溶剂， 生成 2-(bromomethyl)-9H-xanthen-9-one
  参考文献：
  名称：

  新型的高效和选择性非甾体芳香酶抑制剂：合成，生物学评估和结构活性关系研究。

  摘要：

  在进一步寻求有效和选择性芳香化酶抑制剂的过程中，设计并合成了一系列新分子，探索了先前鉴定的x吨酮骨架的可能结构修饰。其中，发现了在低纳摩尔范围内具有抑制活性的高效化合物。特别地，the吨酮核中的杂环氧原子被硫原子取代和/或结构柔性的增加似乎对于与酶的相互作用是有利的。

  DOI：

  10.1021/jm100319h

文献信息

• Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety
  作者：A.M. Waszkielewicz、A. Gunia、N. Szkaradek、K. Pytka、A. Siwek、G. Satała、A.J. Bojarski、E. Szneler、H. Marona

  DOI：10.1016/j.bmcl.2013.05.062

  日期：2013.8

  A series of new xanthone derivatives with piperazine moiety [1–7] was synthesized and evaluated for their pharmacological properties. They were subject to binding assays for α1 and β1 adrenergic as well as 5-HT1A, 5-HT6 and 5-HT7b serotoninergic receptors. Five of the tested compounds were also evaluated for their anticonvulsant properties. The compound 3a 3-methoxy-5-[4-(2-methoxyphenyl)piperazi

  一系列具有哌嗪部分[新呫吨酮衍生物的1 - 7 ]合成并评价它们的药理性质。他们受到结合测定为α 1和β 1肾上腺素能以及5-HT 1A，5-HT 6和5-HT 7B羟色胺受体。还评估了五种测试化合物的抗惊厥特性。化合物3a 3-甲氧基-5-[4-（2-甲氧基苯基）哌嗪-1-基]甲基} -9 H-黄嘌呤-9-盐酸盐对5-羟色胺能5-HT 1A受体具有更高的亲和力（K i = 24 nM）。在抗惊厥活性而言，6-甲氧基-2 - [4-（苄基）哌嗪-1-基]甲基} -9- ħ -呫吨-9-酮（5）被证明最好的性能。在最大电击（MES）癫痫发作测定中确定的ED 50为105 mg / kg bw（大鼠，口服）。an吨与哌嗪部分的组合导致口服给药后获得具有提高的生物利用度的化合物。
• [EN] XANTHONE DERIVATIVES, UV PROTECTIVE COMPOSITION CONCENTRATE, METHOD OF PREPARATION OF UV PROTECTIVE COMPOSITION CONCENTRATE, USE OF UV PROTECTIVE COMPOSITION CONCENTRATE AND COSMETIC UV PROTECTIVE PRODUCT<br/>[FR] DÉRIVÉS DE XANTHONE, CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV, PROCÉDÉ DE PRÉPARATION DE CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV, UTILISATION D'UN CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV ET PRODUIT COSMÉTIQUE DE PROTECTION CONTRE LES UV
  申请人：UNIV JAGIELLONSKI

  公开号：WO2021215943A1

  公开（公告）日：2021-10-28

  The first object of the invention is a xanthone derivative described by formula (I) where R1 is a substituent selected from the group comprising: hydrogen or alkoxy group; R2 is a substituent selected from the group comprising methylcinnamoyl, phenylpenta-2,4- dienenitrile, cyanoethenylphenyl or cyanoethenylalkyl substituent, wherein the phenyl ring is substituted with R3 selected from the group consisting of: hydrogen, alkoxy substituent or halide atom. The second objection of the invention is a UV protective composition concentrate containing the xanthone derivative described by the formula (I). The third object of the invention is a method for the preparation of a UV protective composition concentrate. The next object of the invention is the use of a UV protective composition concentrate for the production of UV protective cosmetic products. Yet another object of the invention is a cosmetic UV protective product.

  该发明的第一个对象是一种黄酮衍生物，其化学式为（I），其中R1是从包括：氢或烷氧基的基团中选择的取代基；R2是从包括：甲基肉桂酰基、苯基戊-2,4-二烯腈基、氰基乙烯基苯基或氰基乙烯基取代基中选择的取代基，其中苯环与R3选择自包括：氢、烷氧基取代基或卤素原子的基团。该发明的第二个对象是一种含有上述化学式（I）所述黄酮衍生物的紫外线防护组合物浓缩物。该发明的第三个对象是一种制备紫外线防护组合物浓缩物的方法。该发明的下一个对象是利用紫外线防护组合物浓缩物生产紫外线防护化妆品产品。该发明的另一个对象是一种化妆用紫外线防护产品。
• Quinuclidine derivative having tricyclic hetero condensed ring
  申请人：Yamanouchi Pharmaceutical Co., Ltd.

  公开号：US05830902A1

  公开（公告）日：1998-11-03

  A quinuclidine derivative represented by the following general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, which has strong squalene synthase inhibiting activity and is useful as a cholesterol lowering agent without causing side effects. ##STR1## (Symbols in the formula represent the following meanings; R.sub.1 : a hydrogen atom, a halogen atom or a lower alkyl group, R.sub.2 : a hydrogen atom, a hydroxyl group or a lower alkoxy group, . . : a single bond or a double bond, with the proviso that R.sub.2 does not exist when . . . is a double bond, X and Y: the same or different from each other and each represents a bond, an oxygen atom (--O--), a carbonyl group (--CO--), a group represented by the formula --S(O).sub.p -- or a group represented by the formula --NR.sub.3 --, p: 0, 1 or 2, R.sub.3 : a hydrogen atom or a lower alkyl group which may have a substituent, A: a saturated or unsaturated lower alkylene group, a group of the formula --(CH.sub.2).sub.m Z(CH.sub.2).sub.n -- or a group of the formula --(CH.sub.2).sub.m Z(CH.sub.2).sub.n CR.sub.4 =, Z: an oxygen atom (--O--), a group of the formula --S(O).sub.q --, a carbonyl group (--CO--) or a group of the formula --NR.sub.5 --, R.sub.4 : a hydrogen atom, a halogen atom or a lower alkyl group, R.sub.5 : a hydrogen atom or a lower alkyl group, m and n: the same or different from each other and each is 0 or an integer of 1 to 5, m+n: an integer of 1 to 5 q: 0, 1 or 2, with the proviso that, when either one of X and Y is a bond, A is a group represented by the formula --(CH.sub.2).sub.m Z(CH.sub.2).sub.n CR.sub.4 =.)

  一种以以下一般式（I）表示的喹诺啉衍生物，其药学上可接受的盐、水合物或溶剂化合物，具有强烈的角鲨烯合酶抑制活性，可用作降低胆固醇的药物，而不会引起副作用。##STR1##（式中的符号表示以下含义；R.sub.1：氢原子、卤原子或较低的烷基基团，R.sub.2：氢原子、羟基或较低的烷氧基团，...：单键或双键，条件是当...为双键时，R.sub.2不存在，X和Y：相同或不同，每个代表键，氧原子（--O--），羰基（--CO--），由式--S(O).sub.p --表示的基团或由式--NR.sub.3 --表示的基团，p：0、1或2，R.sub.3：氢原子或可能具有取代基的较低烷基基团，A：饱和或不饱和的较低烷基基团，式--(CH.sub.2).sub.m Z(CH.sub.2).sub.n --的基团或式--(CH.sub.2).sub.m Z(CH.sub.2).sub.n CR.sub.4 =的基团，Z：氧原子（--O--），式--S(O).sub.q --的基团，羰基（--CO--）或式--NR.sub.5 --的基团，R.sub.4：氢原子、卤原子或较低烷基基团，R.sub.5：氢原子或较低烷基基团，m和n：相同或不同，每个为0或1至5的整数，m+n：1至5的整数，q：0、1或2，条件是当X和Y中的任一个为键时，A为由式--(CH.sub.2).sub.m Z(CH.sub.2).sub.n CR.sub.4 =表示的基团。
• NOVEL QUINUCLIDINE DERIVATIVES HAVING TRICYCLIC FUSED HETERO RING
  申请人：YAMANOUCHI PHARMACEUTICAL CO. LTD.

  公开号：EP0812840A1

  公开（公告）日：1997-12-17

  A quinuclidine derivative represented by the following general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, which has strong squalene synthase inhibiting activity and is useful as a cholesterol lowering agent without causing side effects. (Symbols in the formula represent the following meanings; R1: a hydrogen atom, a halogen atom or a lower alkyl group, R2: a hydrogen atom, a hydroxyl group or a lower alkoxy group, : a single bond or a double bond, with the proviso that R2 does not exist when is a double bond, X and Y: the same or different from each other and each represents a bond, an oxygen atom (-O-), a carbonyl group (-CO-), a group represented by the formula -S(O)p- or a group represented by the formula -NR3-, p: 0, 1 or 2, R3: a hydrogen atom or a lower alkyl group which may have a substituent, A: a saturated or unsaturated lower alkylene group, a group of the formula -(CH2)mZ(CH2)n- or a group of the formula -(CH2)mZ(CH2)nCR4=, Z: an oxygen atom (-O-), a group of the formula -S(O)q-, a carbonyl group (-CO-) or a group of the formula -NR5-, R4: a hydrogen atom, a halogen atom or a lower alkyl group, R5: a hydrogen atom or a lower alkyl group, m and n: the same or different from each other and each is 0 or an integer of 1 to 5, m + n: an integer of 1 to 5 q: 0, 1 or 2, with the proviso that, when either one of X and Y is a bond, A is a group represented by the formula -(CH2)mZ(CH2)nCR4=.)

  一种由以下通式（I）代表的喹烯酮衍生物、其药学上可接受的盐、其水合物或其溶液，该衍生物具有很强的角鲨烯合成酶抑制活性，可用作降低胆固醇的药物，且不会产生副作用。 (式中符号代表以下含义； R1：氢原子、卤素原子或低级烷基、 R2：氢原子、羟基或低级烷氧基、 R2：单键或双键，但 R2 为双键时不存在、 X和Y：彼此相同或不同，各自代表一个键、一个氧原子（-O-）、一个羰基（-CO-）、一个由式-S(O)p-代表的基团或一个由式-NR3-代表的基团、 p:0、1 或 2、 R3：氢原子或可带有取代基的低级烷基、 A：饱和或不饱和低级亚烷基、式-(CH2)mZ( )n-或式-( )mZ( )nCR4=的基团、 Z：氧原子（-O-）、式-S(O)q-的基团、羰基（-CO-）或式-NR5-的基团、 R4：氢原子、卤素原子或低级烷基、 R5：氢原子或低级烷基、 m 和 n：相同或互不相同，各自为 0 或 1 至 5 的整数、 m+n：1 至 5 的整数 q：0、1 或 2、 但条件是，当 X 和 Y 中任何一个是键时，A 是由式-( )mZ( )nCR4=代表的基团。）
• Allylamine Type Xanthone Antimycotics
  作者：Isabella Salmoiraghi、Maddalena Rossi、Piero Valenti、Paolo Da Re

  DOI：10.1002/(sici)1521-4184(199806)331:6<225::aid-ardp225>3.0.co;2-5

  日期：1998.6

  A number of xanthone derivatives bearing the basic chain of naftifine and butenafine antimycotics in 1, 2, 3, and 4 nuclear positions are described. The in vitro antifungal activity against representative strains of molds and yeasts is reported. Only butenafine xanthone analogues shaw significant activity against Cryptococcus neoformans, in particular the regioisomer 4d (1.5 mu g/ml).